News

US lawmakers back ‘right to try’ legislation

https://pharmaphorum.com/news/us-lawmakers-back-right-to-try-legislation/

LuViva scanner could provide alternative to smear test

https://pharmaphorum.com/news/luviva-scanner-could-provide-alternative-to-smear-test/

Amgen’s Repatha gets EU cardio risk reduction label

https://pharmaphorum.com/news/amgens-repatha-gets-eu-cardio-risk-reduction-label/

May champions AI-backed R&D into cancer and chronic disease

https://pharmaphorum.com/news/may-champions-ai-backed-rd-into-cancer-and-chronic-disease/

Spark/Pfizer eye phase 3 trial of haemophilia B gene therapy

https://pharmaphorum.com/news/spark-pfizers-haemophilia-b-drug-dramatically-reduces-bleeds/

Nektar, BioMarin, and Alnylam top list of biotech M&A targets

https://pharmaphorum.com/news/nektar-biomarin-and-alnylam-top-list-of-biotech-ma-targets/

Roche haemophilia data piles pressure on Shire

https://pharmaphorum.com/news/roche-haemophilia-data-piles-pressure-on-shire/

AZ’s potassium drug Lokelma finally approved in US

https://pharmaphorum.com/news/azs-lokelma-finally-approved-in-us/

GSK’s blockbuster HIV drug linked with birth defects

https://pharmaphorum.com/news/gsk-blockbuster-hiv-drug-linked-with-birth-defects/

Close in 10 seconds

Pharmaphorum.com

Search